Search

everythinglearnresearchcommunity

for

Search:↓

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Women with cicatricial hair loss may have a higher risk of hypertension.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Older age and specific haircare practices increase the risk of traction alopecia, and education on these factors could help prevent it.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Many Iraqi women with hirsutism also have hypothyroidism and acne.